Join us for Lygature LIVE!
We kindly invite you to Lygature LIVE, our annual stakeholder event that brings together leaders from academia, industry, patient organisations, and policy makers to exchange insights and help shape the future of health innovation.
This year’s edition celebrates 20 years of pioneering partnerships for patient impact, connecting the past and future of collaboration in life sciences.
Lygature LIVE offers you a unique opportunity to learn from the real‑world challenges and outcomes of collaborative health partnerships - while also connecting with a vibrant network of stakeholders committed to improving health, now and in the future.
Recent news
-
Lygature contributes to PharmaNL 2026 investment agenda shaping the future of pharmaceutical innovation in the Netherlands
During a recent PharmaNL Community Event in Utrecht, more than 80 stakeholders from across the sector gathered to discuss the future of pharmaceutical innovation in the Netherlands and for the presentation of the 2026 PharmaNL Investment Agenda. -
Lygature Contributes to the Future of European Health Data and AI
Through its contribution to the IDERHA project, Lygature is helping shape the future of responsible health data use and AI-enabled healthcare innovation in Europe. In a newly published article in Open Research Europe, Lygature colleagues Erwin Boutsma and Tieneke Schaaij-Visser, together -
Contributing to Dutch Success in European Health Innovation
Dutch organisations have secured more than €5 billion in Horizon Europe funding, marking an important milestone for the Netherlands' leading position in the European research and innovation ecosystem. Within the health domain, Lygature has contributed to this success through dozens of European collaborative projects.
Our value proposition
Accelerating the development of new medical solutions for patients
Lygature aims to accelerate the development of new medical solutions for patients by driving public-private collaboration between academia, industry and society. We are a not-for-profit organization that enables, drives and supports partnerships to address unmet medical needs.
-
Creating a safe space for innovation
-
Driving the partnership forward to deliver medical solutions
-
Providing specialized support for partnerships
Our projects
-
AI4NTD
An international public-private collaboration working together to develop an automated AI-driven tool for the diagnosis and surveillance of neglected tropical diseases, at the first instance for soil-transmitted helminthiasis and schistosomiasis -
Personal Health Train
Connecting health data for health care and research -
HPV-kankervrij.nl
Supporting healthcare professionals in eradicating HPV-related cancers. -
Health Innovation Netherlands
Bringing Health Innovation to the next level -
FAIRplus
The FAIRplus project aims to develop tools and guidelines for making life science data FAIR -
CONTRAST 2.0
A multi-stakeholder effort continued from CONTRAST to develop innovative stroke treatments and how logistics of treatment can be improved. -
Translational Research IT (TraIT)
Implementing and sustaining a long-lasting IT infrastructure for translational research -
DELIVER
Deliberative improvement of oral care quality -
ReSToRe
Joining efforts to bring antigen-specific therapy for multiple sclerosis to the clinic -
BBMRI.nl
Making biosamples, images and data findable, accessible and usable for health research. -
COREON
Committee and expert network of researchers on Regulation of Health Research -
PERSIST-SEQ
The PERSIST-SEQ project aims to build a reproducible single-cell sequencing workflow to capture tumour persistence -
Immune-Image
Specific Imaging of Immune Cell Dynamics using novel tracer strategies -
PREDICTOM
Public private partnership to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform. -
MOMENTUM
Creating a data repository for tracking outcomes of combining imaging and treatment of common cancer types -
ILLUMINATE
ILLUMINATE aims to transform theranostics-based advanced cancer treatment by enhancing metabolic imaging and increasing the sustainable production of the radioisotope lutetium.